Latest Blogs

Sep 19, 2019
Imagine a world in which global oncology is studied as rigorously as hematology/oncology, palliative medicine, or public health. What might we accomplish?
Sep 11, 2019
Bringing together research from all the world is the best way to advance medicine. Enter, ASCO Breakthrough.
Sep 09, 2019
A recent study on the risk of Alzheimer's disease or dementia following the use of ADT was disturbing to me on two levels.
Sep 09, 2019
An inaccurate prognosis given at an urgent care center destroyed my patient's hope. Little by little, I will try to help him rebuild it.
Subscribe to this column

Don S. Dizon, MD, FACP, FASCO

Don S. Dizon, MD, FACP, FASCO, is head of Women's Cancers at Lifespan Cancer Institute, director of Medical Oncology at Rhode Island Hospital, and a professor of medicine at The Warren Alpert Medical School of Brown University. Dr. Dizon serves as chair of ASCO's Social Media Working Group and is a past chair of the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the Journal of Clinical Oncology Editorial Board, and editor in chief of the ASCO Educational BookFollow Dr. Dizon on Twitter @drdonsdizon.

Oct 17, 2017
Every now and then, I have a patient who chooses not to pursue the regimen that I think will bring them the best chances.
Sep 26, 2017
I often wonder if patients know what it’s like to leave a clinical practice for us as clinicians—if they wonder if they ever cross our minds. I hope with this blog I can answer that not only for myself, but for my compassionate colleagues who have chosen medicine, and specifically oncology.
Sep 12, 2017
I applaud the Foundation for Women’s Cancers for highlighting the importance of trials, and join them in their push for more trial options for not only my own patients, but for all patients with cancer.
Aug 29, 2017
As I prepare to take on a new professional position, I have been reflecting on what academic medicine means, and how to thrive in it.
Aug 01, 2017
Yes, "at least" my patient was still alive. But, at the end of the day, I knew that would not be comforting. “At least” is never enough, because when it comes to life, most of us—cancer or no cancer—always want more.
Jun 20, 2017
New immunotherapies are offering astounding responses, but my patient's remission came at the cost of debilitating toxicity. How much is too much to bear?

Pages